Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT. Read more about Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT.
Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas. Read more about Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas.
Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival. Read more about Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival.
Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy. Read more about Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy.
Combining cellular and gene therapy approaches for treatment of intracranial tumors. Read more about Combining cellular and gene therapy approaches for treatment of intracranial tumors.
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Read more about Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease.
Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma. Read more about Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma.
